KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Regeneron Pharmaceuticals (REGN) Tax Rate (2016 - 2025)

Regeneron Pharmaceuticals (REGN) has 14 years of Tax Rate data on record, last reported at 19.08% in Q4 2025.

  • For Q4 2025, Tax Rate rose 1486.0% year-over-year to 19.08%; the TTM value through Dec 2025 reached 13.88%, up 619.0%, while the annual FY2025 figure was 13.88%, 619.0% up from the prior year.
  • Tax Rate reached 19.08% in Q4 2025 per REGN's latest filing, up from 17.2% in the prior quarter.
  • Across five years, Tax Rate topped out at 23.21% in Q4 2022 and bottomed at 3.04% in Q1 2024.
  • Average Tax Rate over 5 years is 10.36%, with a median of 10.61% recorded in 2025.
  • Peak YoY movement for Tax Rate: soared 1507bps in 2021, then tumbled -2425bps in 2023.
  • A 5-year view of Tax Rate shows it stood at 17.42% in 2021, then skyrocketed by 33bps to 23.21% in 2022, then plummeted by -105bps to 1.05% in 2023, then skyrocketed by 503bps to 4.22% in 2024, then soared by 352bps to 19.08% in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Rate were 19.08% in Q4 2025, 17.2% in Q3 2025, and 8.37% in Q2 2025.